Unlock instant, AI-driven research and patent intelligence for your innovation.
4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of hydroxybenzene and compounds, applied in the field of compounds and their medical applications, can solve problems such as difficult to control intestinal symptoms
Active Publication Date: 2019-06-14
SHENYANG UNIV
View PDF3 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, Xenical is the best-selling pancreatic lipase inhibitor in the market, which has the characteristics of strong activity and good stability, but it also has the disadvantages of difficult-to-control intestinal symptoms, greasy stools, vomiting and abdominal distension.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0054] Example 1: Preparation of 4-[(4-phenylpiperazin-1-yl)methyl]-7-hydroxybenzofuran (B01)
[0055] Add 4.0 g (0.030mol) of 7-hydroxybenzofuran, 4.9 g (0.030mol) of 1-phenylpiperazine, 2.4 mL (0.033mol) of 37% aqueous formaldehyde solution, and 1 mL of glacial acetic acid into the reaction flask, and use an appropriate amount of ethanol as a solvent. Heat to reflux for 4~8h, TLC monitors the reaction process, after the reaction is completed, cool down, and remove ethanol by rotary evaporation to obtain a yellow oil, which is separated and purified by column chromatography with ethyl acetate:petroleumether (1:5) as eluent , the solvent was removed by rotary evaporation, and 3.0 g of a light yellow solid was precipitated by freezing, with a yield of 32.5%. ESI-MSm / z: 309.2; 1H-NMR (CDCl3) δ(ppm): 2.62-2.67 (4H, m), 3.16-3.20 (4H, m), 3.56(2H, s), 6.70(1H, m) , 6.80(1H, d, J=8.1 Hz), 6.98-7.08(2H, m), 7.16-7.22 (4H, m), 7.68(1H, d, J=8.1 Hz).
Embodiment 2
[0056] Example 2: Preparation of 4-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-7-hydroxybenzofuran (B02)
[0057]According to the preparation method of Example 1, a light yellow solid was obtained with a yield of 22.7%. ESI-MS m / z: 351.4; 1H-NMR(CDCl3) δ(ppm): 2.28 (3H, s), 2.67-2.72 (4H, m), 3.20-3.35 (4H, m), 3.60 (2H, s ), 6.70(1H, d, J=8.1 Hz), 6.96 (2H, d, J = 8.2 Hz), 7.00-7.06(2H, m), 7.16(2H, d, J=8.2 Hz), 7.72(1H , d, J=8.1 Hz).
Embodiment 3
[0058] Example 3: Preparation of 4-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-7-hydroxybenzofuran (B03)
[0059] According to the preparation method of Example 1, a light yellow solid was obtained with a yield of 23.8%. ESI-MS m / z: 351.4; 1H-NMR(CDCl3) δ(ppm): 2.30 (3H, s), 2.60-2.68 (4H, m), 3.28-3.36 (4H, m), 3.66 (2H, s ), 6.56-6.64 (1H, m), 6.77(1H, d, J=8.1 Hz), 6.94-7.03(3H, m), 7.08-7.13(2H, m), 7.82(1H, d, J=8.1 Hz).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a 4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof, and relates to a compound and medical application thereof. The compound comprises the 4-piperazinemethyl-7-hydroxybenzofuran compound shown as a formula I as well as stereoisomers and pharmaceutically acceptable salts of the compound. The formula I is shown in the description, wherein Ar is independently selected from phenyl, C1-C4 alkyl-substituted phenyl, C1-C4 alkoxy-substituted phenyl, halogen-substituted phenyl and cyano-substituted phenyl. The compound provided by the invention can be applied to effective lipase inhibition medicines, is especially used as a novel nutrient absorption reducing agent, can act on gastrointestinal tract, is capable of inhibiting catalysis and decomposition of lipase and inhibiting absorption of part of fat from dietary intake, is applicable to obesity, and is suitable for obese people including healthy obese people and obese people with non-insulin-dependent diabetes mellitus.
Description
technical field [0001] The invention relates to a compound and its medical use, in particular to a 4-piperazinemethyl-7-hydroxybenzofuran compound and its medical use. Background technique [0002] Obesity is a common disease worldwide. In recent years, the incidence of obesity has been increasing all over the world, especially in developed countries. Due to the rapid development of the economy and the continuous improvement of living standards, the problems of insufficient exercise and relative excess energy intake have always existed in the lifestyle of modern people, which has led to the energy intake of many modern people exceeding energy consumption, and the excess energy Part of it will be stored as fat in adipose tissue, leading to obesity, and obesity can cause a variety of metabolic abnormalities, which is one of the main risk factors for diabetes and cardiovascular diseases, and is associated with increased morbidity and mortality of cardiovascular diseases . At ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More